PMC5869570_01
Skin lesions 25 days after the start of vemurafenib.
cro-0011-0119-g01.jpg
PMC5869570_01_cro-0011-0119-g01.jpg
F1
At a gestational age of 262/7 weeks, 25 days after the start of vemurafenib and within 1 day after intubation, the patient was transferred in a sedated state to an academic centre with both a neonatal intensive care unit (NICU) and burn specialty unit to provide optimal care for her second-degree TEN lesions, which now covered 98% of her body and oral mucosa (Fig. 1).